MRNY Analysis
YieldMax MRNA Option Income Strategy ETF — is the distribution income, or your own capital coming back?
Partly returned capital
Over the last 1Y, MRNY's 73.0% distribution yield was offset by a 30.1% NAV decline, leaving a real yield of 20.9%. Only about 29% of the headline yield was economically yours.
From here, MRNY would need a 43% price gain just to return to where it started the window — before any further distributions are counted.
This verdict is generated from fixed thresholds applied to live price and distribution data, not written per fund. Two funds with the same profile always get the same wording.
How MRNY generates income
MRNY is a YieldMax single-stock option income ETF that generates weekly distributions by selling (writing) call option spreads on MRNA. The fund doesn't simply hold MRNA shares — instead, it uses a synthetic options strategy with U.S. Treasury securities as collateral to create exposure to MRNA while harvesting option premiums.
Each week, the fund sells call options on MRNA at strike prices above the current market price. The premiums collected from these sales are the primary source of the distributions paid to shareholders. When MRNA's implied volatility is high, option premiums are larger and distributions tend to be bigger. When volatility is low, distributions shrink.
The core trade-off: your upside participation in MRNA's price gains is capped at the sold call strike price. If MRNA rallies sharply, MRNY will underperform holding MRNA directly. In exchange, you receive weekly income that can be substantial — but it's not guaranteed and varies with market conditions.
A significant portion of MRNY's distributions may be classified as return of capital (ROC). This is not taxable income — it reduces your cost basis instead. Check the ROC % in the latest distribution announcement above to understand how much of your "dividend" is actually your own capital being returned.
- Underlying
- MRNA
- Strategy
- Call option spreads on MRNA
- Income source
- Option premiums
- Distribution
- Weekly (Group 2, Wednesday)
- Expense ratio
- 0.99%
- Issuer
- YieldMax (Tidal Financial)
MRNY price return since first distribution
The capital half of total return. Read it against the cumulative distributions below — the two together are what a holder actually earned.
Cumulative price return: -92.59%
Want this chart with MRNA, peer funds, and the S&P overlaid on one axis? Koyfin does that — 20% off through our link (Affiliate link — we earn a commission if you subscribe, at no extra cost to you.)
Cumulative distributions collected
Running total of per-share distributions since the first payment on record — 66 payments.
Total collected per share since inception: $21.89
Go deeper on MRNY than this page can
This page answers one question well: did MRNY's distributions outrun its NAV. Koyfin answers the rest — options-implied volatility on MRNA, holdings, correlation, and custom dashboards tracking your whole income sleeve. Our link gets you 20% off the first year.
Affiliate link — we earn a commission if you subscribe, at no extra cost to you. Full disclosure.